Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00142571
Status:
COMPLETED
Last Update Posted:
2007-10-02
First Post:
2005-08-31
Brief Title:
Comparison of Gemcitabine v Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Organization Data
Organization:
Memorial Sloan Kettering Cancer Center
Class:
OTHER
Study ID:
02-129
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Michigan Rogel Cancer Center | OTHER |
| Connective Tissue Oncology Society | OTHER |
| MD Anderson Cancer Center | OTHER |
| Massachusetts General Hospital | OTHER |
| Mayo Clinic | OTHER |